Dr. Ivan Chaitowitz, MD
Interventional Radiology (Vascular & Interventional Radiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 42
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 268
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular & Interventional Radiology Physician primary
FL license MFC1632 -
Diagnostic Radiology Physician
FL license MFC1632
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University of Miami (2,377 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 268
- Services billed
- 581
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 189 | 174 |
| Injection of substance into lower spine canal using imaging guidance | 88 | 68 |
| Review by radiologist of ct guidance for needle placement | 71 | 70 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 53 | 52 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 34 | 28 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 30 | 29 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 21 | 11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | 16 |
| Biopsy of bone marrow | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $104 in total to this clinician.
| GE Healthcare | $58.60 |
|---|---|
| Exelixis Inc. | $24.89 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.28 |
| Food and Beverage | $104 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.